| |
 | Enjoy your bi-weekly dose of all things medical – welcome to our English newsletter! |
|
 | | | | | | | | After the initial excitement about the first malaria vaccine, expectations were severely dampened when only a modest efficacy was reported. However, four years after the rollout began, it becomes clear just how many lives were saved. more | |
| | | | | | Fuel To The Opioid Fire: Nitazene | | | | Nitazene might jumpstart an opioid epidemic in Europe. It is highly addictive with a potency significantly higher than fentanyl or heroin. Here is everything you need to know about the drug. more |
|
| |
| | |
| | | ME/CFS: Comeback Of A Therapy | | | | When it comes to ME/CFS, many therapy options have been tried and failed. Cognitive behavioral therapy has been ruled out early on – but might now make a surprise return. more |
|
| |
| | |
| | | When Every Minute Counts | | | | Receiving a clot-busting drug in an ambulance-based mobile stroke unit increases the likelihood of averting strokes and complete recovery. US researchers now plead for mobile solutions. more |
|
| |
| | |
|
| |
| |
|
| |
| You are receiving this email because you have subscribed to DocCheck News. |
